INVIVO CHARACTERIZATION OF A DOXORUBICIN RESISTANT B16-MELANOMA CELL-LINE

[1] BIEDLER JL, 1983, CANCER TREAT REP, V67, P859

[2] MEMBRANE-MEDIATED DRUG-RESISTANCE AND PHENOTYPIC REVERSION TO NORMAL GROWTH-BEHAVIOR OF CHINESE-HAMSTER CELLS [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (03) : 671 - 680

[3] DANO K, 1972, CANCER CHEMOTH REP 1, V56, P321

[4] ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 323 (03) : 466 - 483

[5] DINCALCI M, 1983, CANCER RES, V43, P5674

[6] ELBE B, 1973, ARCH GESCHWULSTFORSC, V41, P137

[7] FORMELLI F, 1986, CANCER CHEMOTH PHARM, V16, P15

[8] Geran RI, 1972, CANCER CHEMOTHERAPY

[9] GIAVAZZI R, 1983, CANCER RES, V43, P2216

[10] HART IR, 1983, CANCER RES, V43, P400

[1] BIEDLER JL, 1983, CANCER TREAT REP, V67, P859

[2] MEMBRANE-MEDIATED DRUG-RESISTANCE AND PHENOTYPIC REVERSION TO NORMAL GROWTH-BEHAVIOR OF CHINESE-HAMSTER CELLS [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (03) : 671 - 680

[3] DANO K, 1972, CANCER CHEMOTH REP 1, V56, P321

[4] ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 323 (03) : 466 - 483

[5] DINCALCI M, 1983, CANCER RES, V43, P5674

[6] ELBE B, 1973, ARCH GESCHWULSTFORSC, V41, P137

[7] FORMELLI F, 1986, CANCER CHEMOTH PHARM, V16, P15

[8] Geran RI, 1972, CANCER CHEMOTHERAPY

[9] GIAVAZZI R, 1983, CANCER RES, V43, P2216

[10] HART IR, 1983, CANCER RES, V43, P400